He has the disease and he’s lost five family members to it, now he’s enrolled in a study hoping to find some answers in Alzheimer’s disease.
Man looking for answers with new Alzheimer’s study (Links to an external site)
Category: News
Trial aims to prevent Alzheimer’s in those genetically predisposed (Links to an external site)
A first-of-its-kind study is testing the use of antibody drugs to prevent or slow down the onset of Alzheimer’s disease in individuals genetically destined to develop the illness at an early age.
Screening for Alzheimer’s Gene Tests the Desire to Know (Links to an external site)
The Hardest Test: Tucson family has hereditary Alzheimer’s (Links to an external site)
Dominantly Inherited Alzheimer’s Network-Trials Unit on PBS (Links to an external site)
Brian and Amelia Cottle’s story: Living with early onset Alzheimer’s disease (Links to an external site)
Dominantly Inherited Alzheimer Network Trial Completes Participant Enrollment for Two Drugs in Phase II/III Study of Amyloid Therapies (Links to an external site)
2015 Update
The Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) has completed the first stage of participant enrollment in the first Alzheimer’s prevention trial for autosomal dominant Alzheimer’s disease (ADAD), also referred to as early-onset Alzheimer’s disease. The goal of the first stage of the study is to determine the biomarker and cognitive effects of two different […]
34-year-old woman travels to Wash U for Alzheimer’s trial (Links to an external site)
A devastating disease that can rob you of your memory has an Alabama woman traveling to Missouri for help. The mother of three is taking part in a ground breaking study led by Washington University. Carrie Richardson, a 34-year-old preschool teacher and mother of three is in the fight of her life.
First trial to stop Alzheimer’s before symptoms emerge (Links to an external site)
Most research into dementia is about finding treatments for people who are already affected by symptoms. But a trial is under way in London which aims to prevent Alzheimer’s in people at high risk, before they show any physical signs of the disease.